Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 54 citing articles:

Utilization of the microbiome in personalized medicine
Karina Ratiner, Dragos Ciocan, Suhaib K. Abdeen, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 291-308
Closed Access | Times Cited: 44
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 18
Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma
Suki Ha, Vincent Wai‐Sun Wong, Xiang Zhang, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 141-152
Closed Access | Times Cited: 17
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
Giovanni Tarantino, Vincenzo Citro
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
The Role of Cannabidiol in Liver Disease: A Systemic Review
Si Chen, Jeon-Kyung Kim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2370-2370
Open Access | Times Cited: 9
Endogenous ethanol production in health and disease
Abraham S. Meijnikman, Max Nieuwdorp, Bernd Schnabl
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 556-571
Closed Access | Times Cited: 9
Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periosti
Xie Wei, Jing Gan, Xiaodong Zhou, et al.
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1269-1286.e9
Closed Access | Times Cited: 9
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
Serena Porcari, William G. Fusco, Igor Spivak, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 5, pp. 460-475
Closed Access | Times Cited: 8
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 7
Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases
Jumpei Fujiki, Bernd Schnabl
JHEP Reports (2023) Vol. 5, Iss. 12, pp. 100909-100909
Open Access | Times Cited: 16
Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat
Ting-yu Lei, Bin-bin Liao, Liang-Rui Yang, et al.
Microbiological Research (2024) Vol. 288, pp. 127839-127839
Closed Access | Times Cited: 6
New insights into metabolic dysfunction-associated steatotic liver disease and oxidative balance score
Lei Peng, Lurong Li, Jiahao Liu, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 5
The role of the microbiome in liver disease
David Schöler, Bernd Schnabl
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 3, pp. 134-142
Closed Access | Times Cited: 5
Large-scale genomic survey with deep learning-based method reveals strain-level phage specificity determinants
Yi‐Yan Yang, Keith Dufault‐Thompson, Wei Yan, et al.
GigaScience (2024) Vol. 13
Open Access | Times Cited: 5
MetALD: Does it require a different therapeutic option?
George Marek, Harmeet Malhi
Hepatology (2024) Vol. 80, Iss. 6, pp. 1424-1440
Closed Access | Times Cited: 5
Applications of bacteriophages in precision engineering of the human gut microbiome
Xiaoxian Kuang, Juntao Shen, Linggang Zheng, et al.
Engineering Microbiology (2025) Vol. 5, Iss. 1, pp. 100189-100189
Open Access
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease
Andrea Pasta, Elena Formisano, Francesco Calabrese, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 241-241
Open Access
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
Siqi Ren, Yinping Zhang, Xingyue Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Die Darm-Leber-Achse und die metabolische Dysfunktion-assoziierte steatotische Lebererkrankung
Münevver Demir, Frank Tacke, M Müller-Schilling, et al.
Deleted Journal (2025)
Closed Access
Integrative Metabolism in MASLD and MASH: Pathophysiology and Emerging Mechanisms
Gregory R. Steinberg, Celina M. Valvano, William De Nardo, et al.
Journal of Hepatology (2025)
Open Access
Leveraging collateral sensitivity to counteract the evolution of bacteriophage resistance in bacteria
YongQi Mu, Yuqin Song, Xiaofei Tian, et al.
mLife (2025)
Open Access
A Two-Phage Cocktail Modulates Gut Microbiota Composition and Metabolic Profiles in an Ex Vivo Colon Model
Sthefhany Nohemí Rodríguez-Arellano, Jean Pierre González-Gómez, Bruno Gómez‐Gil, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2805-2805
Open Access
Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
Naoko Ohtani, Tomonori Kamiya, Norifumi Kawada
Hepatology Communications (2023) Vol. 7, Iss. 9
Open Access | Times Cited: 14
Increased fecal ethanol and enriched ethanol-producing gut bacteria Limosilactobacillus fermentum, Enterocloster bolteae, Mediterraneibacter gnavus and Streptococcus mutans in nonalcoholic steatohepatitis
Babacar Mbaye, Reham Magdy Wasfy, Patrick Borentain, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
The gut-liver axis in hepatobiliary diseases
Masataka Ichikawa, Haruka Okada, Nobuhiro Nakamoto, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top